All In Biotech

Drug Trial Radar · NCT06602219

A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants With Moderate-to Severe Plaque Psoriasis

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 222 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

222

Actual

Start

Oct 25, 2024

Primary completion

Jul 24, 2025

Study completion Sep 4, 2025

Sponsor

Sponsor type
Industry
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess the safety and efficacy of LY4100511 in adult participants with moderate-to-severe plaque psoriasis.

Conditions

  • Plaque Psoriasis

Interventions

  • LY4100511Drug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving ≥75% Reduction From Baseline in Psoriasis Area and Severity Index (PASI-75) at Week 12 (LY4100511 Versus Placebo)Time frame: Week 12

Locations

58 sites in 7 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology Skin Health Center

    Birmingham, Alabama

  • Dermatology Trial Associates

    Bryant, Arkansas

  • Zenith Research, Inc.

    Beverly Hills, California

  • First OC Dermatology Research Inc

    Fountain Valley, California

  • Center for Dermatology Clinical Research

    Fremont, California

  • Dermatology Research Associates

    Los Angeles, California

  • Clinical Science Institute

    Santa Monica, California

  • Driven Research

    Coral Gables, Florida

  • Direct Helpers Research Center

    Hialeah, Florida

  • Renstar Medical Research

    Ocala, Florida

  • GCP Global Clinical Professionals, LLC

    St. Petersburg, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Endeavor Clinical Trials Center - Dermatology - Skokie

    Skokie, Illinois

  • Lawrence J Green, M.D, LLC

    Rockville, Maryland

  • Center for Clinical Studies, LTD.LLP

    Webster, Texas

  • Interior Dermatology Centre - Probity - PPDS

    Kelowna, British Columbia, Canada

  • Skin Care West

    Nanaimo, British Columbia, Canada

  • Simcoderm Medical & Surgical Dermatology Centre

    Barrie, Ontario, Canada

  • Dermatrials Research Inc.

    Hamilton, Ontario, Canada

  • Lovegrove Dermatology - Probity - PPDS

    London, Ontario, Canada

  • DermEffects - Probity - PPDS

    London, Ontario, Canada

  • Lynderm Research Inc.

    Markham, Ontario, Canada

  • DermEdge Research

    Mississauga, Ontario, Canada

  • Pratia Pardubice a.s. - PRATIA - PPDS

    Pardubice, Czechia

  • Fakultni nemocnice Kralovske Vinohrady

    Prague, Czechia

  • Pratia Prague s.r.o. - PRATIA - PPDS

    Prague, Czechia

  • Kozni ambulance Fialova, s.r.o. - CRC - PPDS

    Prague, Czechia

  • Clintrial s.r.o.

    Prague, Praha 10, Czechia

  • Universitätsklinikum Carl Gustav Carus an der TU

    Dresden, Germany

  • MensingDerma Research GmbH

    Hamburg, Germany

  • Universitätsklinikum Tübingen

    Tübingen, Baden-Wurttemberg, Germany

  • Praxis Dr. med. Virgil-Oreste Mihaescu Facharzt fr Dermatologie und STD

    Augsburg, Bavaria, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt am Main, Hesse, Germany

  • Universitätsklinikum Münster

    Münster, North Rhine-Westphalia, Germany

  • Gyongyosi Bugat Pal Korhaz

    Gyöngyös, Hungary

  • MedMare Bt

    Veszprém, Hungary

  • Debreceni Egyetem Klinikai Kozpont

    Debrecen, Hajdú-Bihar, Hungary

  • Allergo-Derm Bakos Kft

    Szolnok, Jász-Nagykun-Szolnok, Hungary

  • Igarashi Dermatological Clinic

    Tokyo, Japan

  • Nagoya City University Hospital

    Nagoya, Aichi-ken, Japan

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.